meta|evidence oncology
  • Living systematic review and meta-analysis
 
  • metastatic/advanced NSCLC (mNSCLC) - 2nd line (L2) 5
  • mNSCLC - L2 - adenocarcinoma cell
  • mNSCLC - L2 - all population 5
  • mNSCLC - L2 - EGFR high
  • mNSCLC - L2 - EGFR mutant 1
  • mNSCLC - L2 - EGFR wild type
  • mNSCLC - L2 - KRAS mutant
  • mNSCLC - L2 - KRAS wild type
  • mNSCLC - L2 - PDL1 negative 1
  • mNSCLC - L2 - PDL1 positive 7
  • non squamous cell - mNSCLC - L2
  • non squamous - mNSCLC - L2 - all population 1
  • non squamous - mNSCLC - L2 - EGFR mutant
  • non squamous - mNSCLC - L2 - PDL1 positive
  • non squamous - mNSCLC - L2 - wild type (WT)
  • squamous cell - mNSCLC - L2
  • squamous - mNSCLC - L2 - all population 1
  • squamous - mNSCLC - L2 - PDL1 positive